Medtronic brain device OK’d for new use
Medtronic Inc. said Thursday that it has received European regulatory approval to use its deep brain stimulation therapy to control seizures in some epilepsy patients.
The Fridley-based medical technology giant has developed an implantable, pacemaker-like device that delivers controlled electrical pulses to the part of the brain that involve seizures.
European approval, called CE Mark, was based on a 110-patient clinical trial that was conducted at 17 hospitals in the United States, none of them in Minnesota.
While the World Health Organization estimates that 50 million people suffer from epilepsy, Medtronic's recent European approval covers a small subset of adults who suffer from "partial-onset seizures" that affect only a certain part of the brain. These patients typically cannot control their seizures solely with drugs.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- MA an Insurance Proving Ground for Providers
- mHealth Tackles Readmissions
- Targeting Self-Insured Populations
- PCI: Concerns Mount About Appropriateness